News for 'drug money'

Indian Pharma Gets Relief from Trump's Tariffs

Indian Pharma Gets Relief from Trump's Tariffs

Rediff.com4 Apr 2025

Indian drugmakers supply 47 per cent of the generic medicine requirements in the US, and tariffs would have increased prices in the US domestic market for patients, who are already dealing with drug shortages.

Govt unveils Rs 2 trillion dose for jobs, R&D, innovation, growth push

Govt unveils Rs 2 trillion dose for jobs, R&D, innovation, growth push

Rediff.com2 Jul 2025

In a double-dose bid to boost growth and employment prospects, the Union Cabinet on Tuesday approved a Rs 2.07 trillion outlay for a research development and innovation (RDI) Scheme to fund private sector innovations, and an employment-linked incentive (ELI) to create over 35 million new jobs over the next two years.

It Starts With A Casual Bet And Then...

It Starts With A Casual Bet And Then...

Rediff.com4 Jul 2025

In 2025 alone, at least 50 suicides linked to online gambling losses have been reported across India. According to FIRs, the victims were addicted to betting, largely driven by cricket, rummy and poker.

Margin pressures, growth triggers to weigh on Dr Reddy's

Margin pressures, growth triggers to weigh on Dr Reddy's

Rediff.com21 May 2025

Pharma major Dr Reddy's Laboratories delivered a muted operational performance in the fourth quarter of financial year 2024-25 (Q4FY25), even as revenue growth remained healthy. Lower gross margin performance and muted domestic growth are key concerns. Most brokerages have a "Sell" or "Reduce" rating as there are uncertainties related to the development of a new product portfolio and the launch timelines.

Preventive detention must be used sparingly: SC

Preventive detention must be used sparingly: SC

Rediff.com7 Jun 2025

Preventive detention is an extraordinary power in the hands of the state that must be used sparingly, said the Supreme Court as it set aside an order to detain a man indulging in money lending in Kerala.

Sun Pharma Q4 profit down 19% at Rs 2,149.8 cr, revenue up 8%

Sun Pharma Q4 profit down 19% at Rs 2,149.8 cr, revenue up 8%

Rediff.com23 May 2025

India's largest drug maker Sun Pharmaceutical on Thursday posted a decline of 19 per cent year-on-year (Y-o-Y) for its consolidated net profit for the fourth quarter of the financial year 2025 (Q4FY25) at Rs 2,149.8 crore. Meanwhile, its revenue from operations rose by 8 per cent at Rs 12,958.8 crore.

USTR flags hurdles in medical device exports to India

USTR flags hurdles in medical device exports to India

Rediff.com2 Apr 2025

The USTR report, released just ahead of the US' April 2 deadline for implementing reciprocal tariffs, has also cited high tariffs and price caps, which have not increased in line with inflation, as key obstacles for US businesses.

'Digital Arrest?' Don't Panic!

'Digital Arrest?' Don't Panic!

Rediff.com5 May 2025

Targets should avoid panicking and hang up. 'Disconnecting stops the scammers from building psychological pressure.'

GOOD News! No Drug Price Hike In 2024

GOOD News! No Drug Price Hike In 2024

Rediff.com6 Feb 2024

For the consumer, there would be practically no impact on prices of essential medicines this year.

These products account for over 50% of India's exports in FY25

These products account for over 50% of India's exports in FY25

Rediff.com16 May 2025

Agriculture, pharma, electronics, and engineering goods together accounted for over 50 per cent of India's merchandise exports in 2024-25, according to government data, highlighting the country's growing strength in diverse sectors amid efforts to boost manufacturing and value-added exports.

No coercive steps against Wankhede in Sushant drugs case, says HC

No coercive steps against Wankhede in Sushant drugs case, says HC

Rediff.com1 Apr 2024

The Bombay high court on Monday said no coercive steps shall be taken against IRS officer Sameer Wankhede till April 10 on notices issued to him on the NCB's preliminary inquiry over irregularities in a drugs case related to actor Sushant Singh Rajput's death.

SC backs PMLA, says money laundering promotes terrorism, drug trafficking

SC backs PMLA, says money laundering promotes terrorism, drug trafficking

Rediff.com27 Jul 2022

The Supreme Court said on Wednesday that money laundering is a "heinous" crime which not only affects the social and economic fabric of a nation but also tends to promote other serious offences like terrorism and drug trafficking.

TCS calls Gen AI a 'civilisational shift'

TCS calls Gen AI a 'civilisational shift'

Rediff.com28 May 2025

India's largest IT services company TCS believes that generative artificial intelligence (AI) is not just another tech cycle but a "civilisational shift" which will positively benefit every industry.

Zydus gets China nod for kidney disease drug

Zydus gets China nod for kidney disease drug

Rediff.com24 Apr 2024

Ahmedabad-based Zydus Lifesciences said on Tuesday that a new drug application for its oral drug Desidustat used in treating anaemia in chronic kidney disease (CKD) patients had been accepted by the National Medical Products Administration of China (NMPA). In 2020, CMS International Development and Management Ltd, a wholly-owned subsidiary of China Medical System Holdings Ltd obtained an exclusive license for the product from Zydus. CKD involves a gradual loss of functioning of kidneys and eventually leads to kidney failure.

Sameer Wankhede moves HC against ED's money laundering case

Sameer Wankhede moves HC against ED's money laundering case

Rediff.com10 Feb 2024

Wankhede, a 2008-batch Indian Revenue Service (IRS) officer of the Customs and Indirect Taxes cadre, has moved the Bombay High Court seeking protection from any coercive action by the anti-money laundering agency.

India maintains high import duty on American goods: US report

India maintains high import duty on American goods: US report

Rediff.com1 Apr 2025

India maintains "high" import duties on a wide range of American goods such as agricultural items, drug formulations, and alcoholic beverages, besides imposing non-tariif barriers, a US report has said. A day before announcing reciprocal tariffs, the US Trade Representative (USTR) released the 2025 National Trade Estimate (NTE) Report on March 31.

Family of 3 'digitally arrested' for 5 days, duped of Rs 1cr

Family of 3 'digitally arrested' for 5 days, duped of Rs 1cr

Rediff.com11 Feb 2025

A family in Noida was duped of over Rs 1 crore after they were kept under 'digital arrest' for five days by unknown people posing as government officials. The scammers threatened the family with arrest by making video calls and claiming to be investigating money laundering and other crimes. This is a new type of cyber fraud where the accused pose as law enforcement agency officials and use video calls to intimidate their victims.

Wanted Punjab terrorist arrested in US; had links with ISI, BKI

Wanted Punjab terrorist arrested in US; had links with ISI, BKI

Rediff.com18 Apr 2025

Harpreet Singh alias Happy Passia alias Jora, an alleged terrorist who had illegally entered the US, was arrested by the FBI and US Immigration and Customs Enforcement's Enforcement and Removal Operations in Sacramento.

Punjab CM Mann sacks senior cop over nexus with drug traffickers

Punjab CM Mann sacks senior cop over nexus with drug traffickers

Rediff.com18 Apr 2023

Mann also asked the vigilance bureau to investigate the wealth amassed by the police officer through alleged "drug money".

Why India's medical device makers are moving to Vietnam, Malaysia

Why India's medical device makers are moving to Vietnam, Malaysia

Rediff.com14 Mar 2025

A large number of medical device-manufacturing units have been forced to move to Vietnam and Malaysia due to delays, inconsistent timelines, and a lack of transparency in licensing processes, according to the Parliamentary Standing Committee on Health and Family Welfare.

US top trading partner of India for 4th straight year

US top trading partner of India for 4th straight year

Rediff.com16 Apr 2025

The US remained India's largest trading partner for the fourth consecutive year in 2024-25 with bilateral trade valued at $131.84 billion, while the country's trade deficit with China widened to $99.2 billion during the same period, government data showed. In the last fiscal, India's exports to China contracted 14.5 per cent to $14.25 billion as against $16.66 billion in 2023-24. The imports, however, rose by 11.52 per cent in 2024-25 to $113.45 billion against $101.73 billion in 2023-24.

SC quashes chargesheet against former Army officer in rape case

SC quashes chargesheet against former Army officer in rape case

Rediff.com25 Feb 2025

The Supreme Court has quashed a chargesheet against a retired Army officer in an alleged rape case, calling it an "abuse of process of law". The court found that the complainant's testimony showed no offense and the FIR deserved to be quashed. The court also noted that the Delhi High Court erred in its decision of not quashing the chargesheet. The complainant, a woman, had filed multiple FIRs against different persons, allegedly blackmailing them for money. The court concluded that the former Army officer was a "victim of an unscrupulous abuser" of law whose modus operandi was to extort money by misusing the rape and molestation laws.

Tariff war escalates: China warns US of countermeasures, plans WTO suit

Tariff war escalates: China warns US of countermeasures, plans WTO suit

Rediff.com2 Feb 2025

In a statement, the Chinese ministry of commerce said that it would file a lawsuit with the World Trade Organisation against the US for its "wrongful practice," the Global Times reported.

Tariff war: RBI more worried about its impact on growth than inflation

Tariff war: RBI more worried about its impact on growth than inflation

Rediff.com9 Apr 2025

Amid the ongoing global tariff war, Reserve Bank Governor Sanjay Malhotra on Wednesday said he is more worried about its impact on growth than inflation. Speaking to the media after presentation of the first bi-monthly monetary policy for the current financial year, Malhotra said, RBI has reduced the growth forecast for 2025-26 by 20 basis points to 6.5 per cent.

Industry bodies seek safeguards against influx of Chinese goods

Industry bodies seek safeguards against influx of Chinese goods

Rediff.com26 Apr 2025

Various industry bodies have sought immediate government intervention through the imposition of anti-dumping duties, claiming India has seen a surge in imports of Chinese goods over the past two weeks.

'America is back': White House website changes

'America is back': White House website changes

Rediff.com21 Jan 2025

The White House website had a new look with the bold banner headline 'America is back' seconds after Trump was sworn in as the 47th President of the United States on Monday.

Two women among 12 held so far in 3 states on espionage charges

Two women among 12 held so far in 3 states on espionage charges

Rediff.com19 May 2025

While six of them have been held from Punjab, five were nabbed from neighbouring Haryana, and one from Uttar Pradesh.

AI makes mark in drug discovery in India; start-up Peptris raises $1 mn

AI makes mark in drug discovery in India; start-up Peptris raises $1 mn

Rediff.com21 Dec 2023

The process of discovering and developing a new drug can take decades and costs hundreds of millions or even billions of dollars. However, technological advances like artificial intelligence can help speed up and transform the time-consuming and labor-intensive exercise. In India, Peptris Technologies, a Bangalore-based AI drug discovery company, has announced $1 million in pre-seed round investment led by Speciale Invest.

No southern state, including TN, will lose LS seats: Shah

No southern state, including TN, will lose LS seats: Shah

Rediff.com26 Feb 2025

Union Home Minister Amit Shah has refuted claims made by Tamil Nadu Chief Minister M K Stalin regarding fund allocation and delimitation, accusing him of spreading misinformation and engaging in diversionary tactics. Shah asserted that the Modi government has provided significant financial support to Tamil Nadu and denied claims of any reduction in Parliamentary representation for the state following delimitation. He also criticized the DMK government's handling of law and order, citing issues such as drug trafficking and corruption. Shah expressed confidence in the BJP's prospects in the upcoming Assembly elections, predicting a larger victory than in Maharashtra and Haryana.

Family's financial liabilities suspected motive behind Kerala mass murder

Family's financial liabilities suspected motive behind Kerala mass murder

Rediff.com28 Feb 2025

Financial liabilities are suspected to be the motive behind the gruesome mass murder in Kerala's Venjaramoodu, where a man allegedly killed his grandmother, brother, girlfriend, paternal uncle and the latter's wife. The accused, Afan (23), had a debt of over Rs 65 lakh and his family was on the brink of suicide due to the financial burden. The police are investigating all angles, including a possible drug connection.

Trump pauses tariffs as Canada ramps up border security

Trump pauses tariffs as Canada ramps up border security

Rediff.com4 Feb 2025

United States President Donald Trump said on Monday that Canada will implement a $1.3 billion border plan aimed at stopping the flow of fentanyl into the United States.

India, US trade talks likely to resume in Washington

India, US trade talks likely to resume in Washington

Rediff.com17 Apr 2025

An Indian official team is likely to visit Washington next week to iron out differences on certain issues before formally launching negotiations for the proposed India-US bilateral trade agreement (BTA), an official said. The visit, which comes within weeks of a high-level US team visiting India, indicates that the talks for the BTA are gaining momentum.

Budget 2025: What is costlier, what is cheaper

Budget 2025: What is costlier, what is cheaper

Rediff.com2 Feb 2025

Here is a list of items set to become cheaper and costlier.

Health care, pharma IPOs raise Rs 14,811 cr in 2024

Health care, pharma IPOs raise Rs 14,811 cr in 2024

Rediff.com23 Dec 2024

India's healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According to data, key contributors to the record fundraising included Sai Life Sciences (Rs 3,043 crore), IKS Health (Rs 2,498 crore), and Sagility India (Rs 2,107 crore).

India Inc holds breath for Trump's new tariffs to kick in

India Inc holds breath for Trump's new tariffs to kick in

Rediff.com27 Feb 2025

Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.

How China retaliated against Trump's tariffs

How China retaliated against Trump's tariffs

Rediff.com4 Mar 2025

China on Tuesday retaliated US President Donald Trump's imposition of 2nd round of ten per cent tariffs on its export by slapping an additional 15 per cent tariffs on American goods and initiated legal action against Washington in WTO while leaving the door open for talks to address each other's concerns.

Equity market volatility may persist; long-term outlook remains constructive: Experts

Equity market volatility may persist; long-term outlook remains constructive: Experts

Rediff.com3 Apr 2025

The heightened global uncertainty due to the US "reciprocal tariffs" on India may cause near-term corrections and market turbulence, but the long-term outlook remains constructive, market experts said on Thursday. The US has announced 27 per cent reciprocal tariffs on India, citing high import duties imposed by New Delhi on American goods.

'Can someone explain how a negotiation was possible?'

'Can someone explain how a negotiation was possible?'

Rediff.com16 Feb 2025

Rather than face the prospect of a lengthy ban, with a decision expected by the end of the year, World No 1 Jannik Sinner accepted the three-month suspension which will allow him to return before the French Open.

Paranoid India Inc wants early conclusion of trade pact with US

Paranoid India Inc wants early conclusion of trade pact with US

Rediff.com26 Mar 2025

The Indian industry is paranoid about the USA's plan to impose reciprocal tariffs and wants early conclusion of a bilateral trade agreement, sources said on Wednesday. They said that the talks for the proposed bilateral trade agreement are going well.

Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects

Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects

Rediff.com26 Jan 2025

Dr Reddy's Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after analysts remained cautious on the company's Q3 performance and differed on its growth outlook. DRL's Q3 performance was viewed as subdued by some analysts when they adjusted it for one-time grants and incomes that the company received during the quarter.